| __timestamp | AstraZeneca PLC | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 382096000000 |
| Thursday, January 1, 2015 | 5997000000 | 345927000000 |
| Friday, January 1, 2016 | 5890000000 | 312303000000 |
| Sunday, January 1, 2017 | 5757000000 | 325441000000 |
| Monday, January 1, 2018 | 5932000000 | 368298000000 |
| Tuesday, January 1, 2019 | 5958000000 | 492381000000 |
| Wednesday, January 1, 2020 | 5991000000 | 455833000000 |
| Friday, January 1, 2021 | 9736000000 | 526087000000 |
| Saturday, January 1, 2022 | 9762000000 | 633325000000 |
| Sunday, January 1, 2023 | 10935000000 | 729924000000 |
| Monday, January 1, 2024 | 13583000000 | 729924000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, research and development (R&D) investments are pivotal for innovation. Over the past decade, AstraZeneca PLC and Takeda Pharmaceutical Company Limited have demonstrated contrasting strategies in their R&D allocations. From 2014 to 2023, AstraZeneca's R&D expenses grew by approximately 96%, peaking in 2023. This surge underscores their commitment to pioneering new treatments. Meanwhile, Takeda's R&D spending, although consistently higher, increased by about 91% over the same period, reflecting their expansive research initiatives.
Interestingly, 2024 data for AstraZeneca is missing, hinting at potential strategic shifts or reporting delays. Such insights are crucial for stakeholders aiming to understand the competitive dynamics and future trajectories of these pharmaceutical titans. As the industry braces for new challenges, these R&D trends offer a glimpse into the innovative pulse driving global healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and Takeda Pharmaceutical Company Limited
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
R&D Insights: How Takeda Pharmaceutical Company Limited and Madrigal Pharmaceuticals, Inc. Allocate Funds
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated